Latest Period
Q2 2026
Security Snapshot
MEDICINOVA INC - Common Stock, par value $0.001 per share (MNOV) Institutional Ownership
CUSIP: 58468P206
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
29
Shares (Excl. Options)
5,177,954
Price
$1.32
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- MNOV on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 5,177,954
- Total 13F value
- $6,835,508
- Portfolio coverage rank
- 0%
- Share change
- -226,386
- Value change
- -$301,924
- Number of holders
- 29
- Shares outstanding
- 49,111,586
- SEC-reported price per share
- $1.62
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MNOV - MEDICINOVA INC - Common Stock, par value $0.001 per share is tracked under CUSIP 58468P206.
- 29 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 30 to 29 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $7,404,208 to $6,835,508.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 29 institutions filings for Q2 2026.
Security key
58468P206
Latest holder period
Q2 2026
13F holders
29
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
MNOV full holder history
MEDICINOVA INC SEC filings
MEDICINOVA INC company facts
MEDICINOVA INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 58468P206:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
MNOV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| 3D Investment Partners Pte. Ltd. | 9.9% | $7,633,414 | 4,862,047 | 3D Investment Partners Pte. Ltd. | 25 Sep 2026 |
As of 30 Jun 2026, 29 institutional investors reported holding 5,177,954 shares of MEDICINOVA INC - Common Stock, par value $0.001 per share (MNOV). This represents 11% of the company’s total 49,111,586 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
11%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 2.3% | 1,105,941 | 0% | 0.57% | $1,459,842 |
| BlackRock, Inc. | 1.5% | 752,091 | +6.5% | 0% | $992,760 |
| CITIGROUP INC | 1.3% | 635,715 | 0% | 0% | $839,144 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2% | 609,052 | -0.33% | 0% | $803,949 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 539,312 | -0.83% | 0% | $712,087 |
| VANGUARD FIDUCIARY TRUST CO | 0.58% | 282,608 | +0.71% | 0% | $373,043 |
| UBS Group AG | 0.45% | 222,200 | 0% | 0% | $293,304 |
| RENAISSANCE TECHNOLOGIES LLC | 0.42% | 205,400 | +8.2% | 0% | $271,128 |
| STATE STREET CORP | 0.39% | 193,698 | 0% | 0% | $255,681 |
| NORTHERN TRUST CORP | 0.29% | 143,665 | +7.9% | 0% | $189,638 |
| Bank of New York Mellon Corp | 0.16% | 78,277 | 0% | 0% | $103,325 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.15% | 71,506 | 0% | 0% | $94,388 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.11% | 56,031 | 0% | 0% | $73,961 |
| SBI Securities Co., Ltd. | 0.1% | 51,479 | +15% | 0% | $67,952 |
| DIMENSIONAL FUND ADVISORS LP | 0.1% | 50,552 | 0% | 0% | $66,728 |
| BARCLAYS PLC | 0.09% | 42,806 | -74% | 0% | $56,504 |
| Schonfeld Strategic Advisors LLC | 0.07% | 36,157 | -0.6% | 0% | $47,726 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% | 26,752 | -39% | 0% | $35,313 |
| JANE STREET GROUP, LLC | 0.03% | 15,818 | -82% | 0% | $20,880 |
| Vanguard Global Advisers, LLC | 0.03% | 15,599 | 0% | 0% | $20,591 |
| TWO SIGMA INVESTMENTS, LP | 0.03% | 13,526 | -55% | 0% | $17,854 |
| BANK OF AMERICA CORP /DE/ | 0.03% | 13,159 | -62% | 0% | $17,370 |
| Focus Partners Advisor Solutions, LLC | 0.02% | 10,000 | 0% | $13,200 | |
| HANTZ FINANCIAL SERVICES, INC. | 0.01% | 4,232 | 0% | 0% | $6,000 |
| MORGAN STANLEY | 0% | 2,000 | 0% | 0% | $2,640 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 5,177,954 | $6,835,508 | -$301,924 | $1.32 | 29 |
| 2026 Q1 | 5,404,340 | $7,404,208 | -$63,009 | $1.37 | 30 |
| 2025 Q4 | 5,253,134 | $6,882,144 | +$163,841 | $1.31 | 32 |
| 2025 Q3 | 5,128,066 | $6,488,274 | -$53,429 | $1.27 | 25 |
| 2025 Q2 | 5,170,823 | $6,774,834 | -$46,809 | $1.31 | 23 |
| 2025 Q1 | 5,202,397 | $7,595,262 | -$90,880 | $1.46 | 27 |
| 2024 Q4 | 5,231,027 | $10,985,693 | +$513,458 | $2.10 | 29 |
| 2024 Q3 | 4,929,543 | $10,359,167 | +$566,392 | $2.10 | 30 |
| 2024 Q2 | 4,654,818 | $6,706,694 | -$28,677 | $1.44 | 30 |
| 2024 Q1 | 4,674,226 | $6,779,462 | -$233,962 | $1.45 | 32 |
| 2023 Q4 | 4,834,478 | $7,252,924 | -$349,778 | $1.50 | 33 |
| 2023 Q3 | 5,006,666 | $10,465,142 | -$860,474 | $2.09 | 30 |
| 2023 Q2 | 5,381,224 | $12,394,508 | -$434,062 | $2.30 | 33 |
| 2023 Q1 | 5,588,064 | $12,068,850 | -$1,337,380 | $2.16 | 40 |
| 2022 Q4 | 6,208,931 | $12,727,368 | -$1,307,417 | $2.05 | 40 |
| 2022 Q3 | 6,844,003 | $14,850,894 | -$257,655 | $2.17 | 32 |
| 2022 Q2 | 6,960,285 | $17,609,042 | -$424,414 | $2.53 | 33 |
| 2022 Q1 | 7,128,380 | $19,033,559 | -$1,334,125 | $2.67 | 29 |
| 2021 Q4 | 7,622,755 | $20,425,618 | -$239,811 | $2.68 | 40 |
| 2021 Q3 | 7,648,159 | $28,991,165 | -$3,061,081 | $3.79 | 38 |
| 2021 Q2 | 8,411,276 | $35,749,549 | -$15,268,151 | $4.25 | 52 |
| 2021 Q1 | 11,786,829 | $59,521,826 | +$2,083,384 | $5.05 | 57 |
| 2020 Q4 | 11,344,150 | $59,675,777 | +$6,680,486 | $5.26 | 54 |
| 2020 Q3 | 10,076,079 | $52,789,386 | +$2,838,430 | $5.24 | 51 |
| 2020 Q2 | 9,522,886 | $51,614,201 | -$1,218 | $5.42 | 48 |